D. Gorecki

发表

Chloral Hydrate Administration to Neonates: Potential Toxicological Implications

K. Sankaran, K. Hindmarsh, D. Gorecki, 1991 .

Chloral hydrate disposition following single-dose administration to critically ill neonates and children.

D. Mayers, G. Kasian, K. Sankaran, 1991, Developmental pharmacology and therapeutics.

Novel 3,5-bis(arylidene)-4-piperidone dimers: potent cytotoxins against colon cancer cells.

J. Dimmock, D. Michel, U. Das, 2013, European journal of medicinal chemistry.

Evidence-based evaluation of potential benefits and safety of beta-alanine supplementation for military personnel.

R. Maughan, M. Hardy, W. Evans, 2014, Nutrition reviews.

The noncompliance factor in the dexamethasone suppression test

D. Keegan, R. O'reilly, D. Gorecki, 1993, Biological Psychiatry.

Effect of taurine deficiency on tissue taurine concentrations and pregnancy outcome in the rat.

P. Paterson, D. Gorecki, K. Gottschall-Pass, 1995, Canadian journal of physiology and pharmacology.

1.6-Naphathyridines II. 2,3-Distributed derivatives and some new tricyclic ring systems†

D. Gorecki, Edwared M. Hawes and, 1974 .

1,6-NAPHTHYRIDINES PART 2, 2,3-DISUBSTITUTED DERIVATIVES AND SOME NEW TRICYCLIC RING SYSTEMS

D. Gorecki, E. Hawes, 1974 .

Novel 3,5-bis(arylidene)-4-oxo-1-piperidinyl dimers: structure-activity relationships and potent antileukemic and antilymphoma cytotoxicity.

Stephen G. Dimmock, E. De Clercq, J. Dimmock, 2014, European journal of medicinal chemistry.

Bis[3,5‐bis(benzylidene)‐4‐oxo‐1‐piperidinyl]amides: A Novel Class of Potent Cytotoxins

Stephen G. Dimmock, J. Dimmock, J. Balzarini, 2011, ChemMedChem.

2,3-Disubstituted 1,8-naphthyridines as potential diuretic agents. 2. 5,7-Dimethyl derivatives.

D. Gorecki, E. Hawes, R. Gedir, 1977, Journal of medicinal chemistry.

Molecular structure--activity relationship of hydrazides inhibiting glutamic acid decarboxylase, GABA-alpha-oxoglutarate aminotransferase, and monoamine oxidase activities in chick brain.

J. Dimmock, J. Wood, D. Gorecki, 1975, Canadian journal of physiology and pharmacology.

Effect of L-cycloserine on brain GABA metabolism.

J. Wood, S. J. Peesker, D. Gorecki, 1978, Canadian journal of physiology and pharmacology.

E-2-[3-(3,4-dichlorophenyl)-1-oxo-2-propenyl]-3-methylquinoxaline-1,4-dioxide: a lead antitubercular agent which alters mitochondrial respiration in rat liver.

J. Dimmock, U. Das, D. Gorecki, 2010, European journal of medicinal chemistry.

2-amino-3-substituted 1,6-naphthyridines

D. Gorecki, E. Hawes, 1972 .

Adjuvant activities of saponins from the root of Polygala senega L.

D. Gorecki, A. Estrada, B. Barl, 2007, Canadian journal of physiology and pharmacology.

Safety and performance benefits of arginine supplements for military personnel: a systematic review.

R. Maughan, R. Wolfe, M. Hardy, 2016, Nutrition reviews.

Determination of chloral hydrate metabolism in adult and neonate biological fluids after single-dose administration.

K. Sankaran, K. Hindmarsh, D. Gorecki, 1990, Journal of chromatography.

Chloral hydrate sedation in neonates and infants--clinical and pharmacologic considerations.

G. Kasian, K. Sankaran, K. Hindmarsh, 1990, Developmental Pharmacology and Therapeutics.

Sedative/hypnotic effects of chloral hydrate in the neonate: trichloroethanol or parent drug?

D. Mayers, K. Sankaran, K. Hindmarsh, 1992, Developmental pharmacology and therapeutics.

Intravenous Clomipramine and Obsessive-Compulsive Disorder

D. Gorecki, A. Remillard, A. Thakur, 1991, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Depression of the electroretinogram in rats deficient in zinc and taurine during prenatal and postnatal life

B. Grahn, P. Paterson, H. Semple, 1998 .

Oscillatory potentials and light microscopic changes demonstrate an interaction between zinc and taurine in the developing rat retina.

B. Grahn, P. Paterson, D. Gorecki, 1997, The Journal of nutrition.

Vitamin E deficiency and erythrocyte deformability in the rat

R. Card, P. Paterson, D. Gorecki, 1994 .

3,5‐Bis(benzylidene)‐4‐oxo‐1‐phosphonopiperidines and Related Diethyl Esters: Potent Cytotoxins with Multi‐Drug‐Resistance Reverting Properties

E. De Clercq, J. Molnár, J. Dimmock, 2009, ChemMedChem.

In vitro and in vivo assessment of the bioavailability of potassium from a potassium tartrate tablet

S. Whiting, D. Gorecki, Dennis Jones, 1991, Biopharmaceutics & drug disposition.

Dimeric 3,5-bis(benzylidene)-4-piperidones: a novel cluster of tumour-selective cytotoxins possessing multidrug-resistant properties.

J. Molnár, J. Dimmock, H. Sakagami, 2012, European journal of medicinal chemistry.

PHARMACOKINETICS AND TISSUE RESIDUES OF TELAZOL® IN FREE-RANGING POLAR BEARS

S. Farley, M. Ramsay, H. Semple, 2000, Journal of wildlife diseases.

Sequential cytotoxicity: a theory examined using a series of 3,5-bis(benzylidene)-1-diethylphosphono-4-oxopiperidines and related phosphonic acids.

J. Dimmock, H. Sakagami, M. Kawase, 2010, Bioorganic & medicinal chemistry letters.

The effect of some 1-[4-(2-diethylaminoethoxy)phenylcarbonyl]-3,5-bis (benzylidene)-4-piperidone methiodides and related compounds on respiration and swelling of rat liver mitochondria.

J. Dimmock, B. Bandy, U. Das, 2008, Die Pharmazie.

Postnatal Deficiencies of Zinc and Taurine Alter Electroretinograms, Oscillatory Potentials and Morphology of the Rat Retina.

B. Grahn, P. Paterson, H. Semple, 1999, Nutritional neuroscience.

Clinical Application of Pharmacokinetics in Adjusting Gentamicin Dosage: Case Reports

S. Wallace, D. Gorecki, K. Gesy, 1981, Drug intelligence & clinical pharmacy.

An evaluation of gentamicin dosing according to renal function in neonates with suspected sepsis.

K. Sankaran, K. Hindmarsh, D. Gorecki, 1987, American journal of perinatology.

L-α-amino-β-chloropropionic acid hydroxamide: An inhibitor of GABA-α-oxoglutarate aminotransferase

J. Wood, D. Gorecki, C. Charington, 1976 .